These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 7850915

  • 1. Phase II study of a new combined primary chemotherapy regimen, intravenous methotrexate and vincristine and intraarterial adriamycin and cisplatin, for locally advanced urinary bladder cancer: preliminary results.
    Kuroiwa T, Naito S, Hasuo K, Kishikawa T, Masuda K, Kumazawa J.
    Cancer Chemother Pharmacol; 1995; 35(5):357-63. PubMed ID: 7850915
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

  • 3. [Intraarterial COMPA (cis-diammine-dichloroplatinum (II), vincristine, methotrexate, peplomycin, adriamycin) chemotherapy for bladder cancer].
    Tsujino S, Ito T, Aizawa T, Namiki K, Ohno Y, Yamamoto S, Ishibashi K, Miki M, Yamauchi T, Kawai T.
    Hinyokika Kiyo; 1992 Oct; 38(10):1101-7. PubMed ID: 1282770
    [Abstract] [Full Text] [Related]

  • 4. [Intraarterial chemotherapy with bladder preservation in patients with invasive bladder carcinoma].
    Shiba M, Takatera H, Fujii T, Tokizane T, Shimizu K, Tushima J.
    Hinyokika Kiyo; 2004 Jan; 50(1):15-9. PubMed ID: 15032009
    [Abstract] [Full Text] [Related]

  • 5. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
    Yamauchi T, Hida S, Ooishi K, Okada K, Yoshida O.
    Hinyokika Kiyo; 1985 Jul; 31(7):1093-104. PubMed ID: 2414981
    [Abstract] [Full Text] [Related]

  • 6. [Arterial infusion chemotherapy for patients with advanced and moderately advanced cancer of urinary bladder].
    Li Q, Xu X, Liu J.
    Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):308-9. PubMed ID: 10920993
    [Abstract] [Full Text] [Related]

  • 7. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
    Varveris H, Delakas D, Anezinis P, Haldeopoulos D, Mazonakis M, Damilakis J, Metaxaris G, Chondros N, Mavromanolakis E, Daskalopoulos G, Dimitrakopoulos A, Kranidis A.
    Anticancer Res; 1997 Jul; 17(6D):4771-80. PubMed ID: 9494605
    [Abstract] [Full Text] [Related]

  • 8. [Means of effective and practical intra-arterial chemotherapy for locally invasive bladder cancer--with special reference to clinical analysis of bladder cancer patients treated by intermittent intra-arterial infusion using an implantable port system].
    Takashima S, Nakamura K, Nakatsuka H, Ogawa R, Kobashi S, Kaminou T, Matsuoka T, Yamada R, Ezaki K, Wada S, Kishimoto T.
    Hinyokika Kiyo; 1999 Feb; 45(2):127-31. PubMed ID: 10212787
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin-II combined intra-arterial chemotherapy for locally advanced bladder cancer: a case series study at a single institution.
    Shimabukuro T, Nakamura K, Uchiyama K, Tei Y, Aoki A, Naito K.
    Hinyokika Kiyo; 2006 Feb; 52(2):99-105. PubMed ID: 16541762
    [Abstract] [Full Text] [Related]

  • 10. Chemotherapy with methotrexate, carboplatin, mitoxantrone (Novantrone) and vincristine (Oncovin) in transitional-cell urothelial cancer.
    Pectasides D, Mylonakis A, Antoniou F, Kostopoulou M, Triantaphyllis D, Papadopoulou M, Varthalitis J, Dimitriadis M, Athanassiou A.
    Oncology; 1998 Feb; 55(2):139-44. PubMed ID: 9499188
    [Abstract] [Full Text] [Related]

  • 11. Combination chemotherapy with intra-arterial cisplatin and doxorubicin plus intravenous methotrexate and vincristine for locally advanced bladder cancer. Kyushu University Urological and Radiological Oncology Group.
    Naito S, Kuroiwa T, Ueda T, Hasuo K, Masuda K, Kumazawa J.
    J Urol; 1995 Nov; 154(5):1704-9. PubMed ID: 7563327
    [Abstract] [Full Text] [Related]

  • 12. [Combination chemotherapy with methotrexate, vincristine, cisplatinum, cyclophosphamide, adriamycin, and bleomycin (MVP-CAB) for metastatic urothelial cancer].
    Fujii A, Oka N, Miyasaki S, Higuchi A, Itoh N, Okamoto Y, Tanaka H, Hiro-oka K, Shimatani N, Inoue T.
    Nihon Hinyokika Gakkai Zasshi; 1991 Jun; 82(6):932-9. PubMed ID: 1715415
    [Abstract] [Full Text] [Related]

  • 13. [Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) chemotherapy for advanced urothelial cancers].
    Takenaka A, Gotoh A, Hara I, Gohji K, Ogawa T, Arakawa S, Matsumoto O, Kamidono S, Hamami G, Itani A.
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1909-15. PubMed ID: 2393308
    [Abstract] [Full Text] [Related]

  • 14. [Intra-arterial chemotherapy with cisplatin in advanced urothelial cancer].
    Takahashi Y, Uno H, Nagai T, Tamaki M, Nagatani Y, Shinoda I, Takeuchi T, Fujihiro S, Kuriyama M, Kawada Y.
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2806-9. PubMed ID: 2782890
    [Abstract] [Full Text] [Related]

  • 15. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [Abstract] [Full Text] [Related]

  • 16. [Squamous cell carcinoma of the bladder treated with a new combined chemotherapy regimen, intraarterial nedaplatin and pirarubicin plus intravenous methotrexate and vincristine--second case report in Japan].
    Shigehara K, Kitagawa Y, Nakashima T, Shimamura M, Katayanagi K, Kurumaya H.
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1319-21. PubMed ID: 17687223
    [Abstract] [Full Text] [Related]

  • 17. [Combination chemotherapy of methotrexate, etoposide, adriamycin and cisplatin (M-EAP) for advanced urothelial cancer].
    Hashimura T, Okumura K, Akao T, Nakagawa T.
    Hinyokika Kiyo; 1991 Jul; 37(7):685-8. PubMed ID: 1927767
    [Abstract] [Full Text] [Related]

  • 18. [Intra-arterial COMPA chemotherapy for invasive bladder cancer].
    Tsujino S, Yamauchi T, Kokuho M, Kobayashi T, Tachibana Y, Sawano S, Kawai T.
    Nihon Hinyokika Gakkai Zasshi; 1992 Oct; 83(10):1640-6. PubMed ID: 1279259
    [Abstract] [Full Text] [Related]

  • 19. [Intra-arterial infusion chemotherapy of advanced bladder cancer].
    Akiyama M, Inoue Y, Yokota K, Sumiyoshi Y.
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1705-8. PubMed ID: 1530337
    [Abstract] [Full Text] [Related]

  • 20. [M-VAC chemotherapy for patients with lymph node metastases and/or locally advanced bladder carcinoma].
    Igawa M, Ueki T, Ueda M, Okada K, Usui T, Ohnishi Y, Nakatsu H, Kume T, Kodama M, Masu C.
    Hinyokika Kiyo; 1989 Aug; 35(8):1323-7. PubMed ID: 2683648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.